Quest Diagnostics sales and marketing update

Quest launched its EGFR Pathway test in the U.S. for identifying genetic mutations in the K-Ras, neuroblastoma Ras viral (v-Ras) oncogene homolog (NRAS) and BRAF genes. The test predicts which met...